Cyclic AMP plays a role in regulating HDL binding to human cells in culture.
Middleton
A
A
Department of Biochemistry, Nottingham University Medical School.
Middleton
B
B
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D002352:Carrier Proteins; D002478:Cells, Cultured; D002784:Cholesterol / Q000494:pharmacology; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008075:Lipoproteins, HDL / Q000378:metabolism*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism*; D016601:RNA-Binding Proteins; D018110:Receptors, Lipoprotein / Q000187:drug effects / Q000378:metabolism; D013873:Thionucleotides / Q000494:pharmacology
D002352:Carrier Proteins; D008075:Lipoproteins, HDL; D016601:RNA-Binding Proteins; D018110:Receptors, Lipoprotein; D013873:Thionucleotides; C031616:high density lipoprotein receptors; C075197:high density lipoprotein binding protein; D005576:Colforsin; C015929:8-((4-chlorophenyl)thio)cyclic-3',5'-AMP; D003994:Bucladesine; D002784:Cholesterol; D000242:Cyclic AMP; D015056:1-Methyl-3-isobutylxanthine